Superworth

Pacific Biosciences of California EPS PACB

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$0.43
Latest quarter, Q2 FY26
−$0.14
Fiscal year 2025
−$1.84

Pacific Biosciences of California's earnings per share was −$0.43 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.14.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$1.84n/a
FY2024−$1.14n/a
FY2023−$1.21n/a
FY2022−$1.40n/a
FY2021−$0.89−990%
FY2020$0.10n/a
FY2019−$0.55n/a
FY2018−$0.77n/a
FY2017−$0.89n/a
FY2016−$0.84n/a
FY2015−$0.43n/a
FY2014−$0.94n/a
FY2013−$1.27n/a
FY2012−$1.70n/a
FY2011−$2.03n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.14n/a−$0.43
Q1 FY26−$0.03n/a−$0.43
Q4 FY25−$0.13−1400%−$1.84
Q3 FY25−$0.13n/a−$1.70
Q2 FY25−$0.14n/a−$1.79
Q1 FY25−$1.44n/a−$2.29
Q4 FY24$0.01n/a−$1.14
Q3 FY24−$0.22n/a−$1.46
Q2 FY24−$0.64n/a−$1.50
Q1 FY24−$0.29n/a−$1.14
Q4 FY23−$0.31n/a−$1.21
Q3 FY23−$0.26n/a−$1.27

Against its peers

Companies in Medical - Diagnostics & Research nearest Pacific Biosciences of California's size, closest first, today.

CompanyEPS, 12 monthsGrowth
PACBPacific Biosciences of California−$0.43
NRCNRC Health$0.25−67% a year
CDNACareDx$2.07+116% a year
VCYTVeracyte$1.40+324% a year
ICCCImmucell$0.08−58% a year
BLLNBillionToOne$0.65
LNTHLantheus$4.13+10% a year
Peer median$1.02

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Pacific Biosciences of California

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.